Subscribe
e.g. organoids

Agendia Announces First Patient Enrolled in PROOFS Registry Trial to Determine Optimal Treatment and Ability to Forgo Chemotherapy for Premenopausal Women with Early HR+ Breast Cancer

Agendia, Inc. announced the first patient has been enrolled in the PROOFS Registry trial. The study aims to determine whether premenopausal women with early HR+ breast cancer can avoid chemotherapy, and maintain strong outcomes by opting instead for temporary ovarian function suppression in combination with endocrine therapy.
[Agendia, Inc.]
Press Release
Published In
NewslettersMammary Cell News
spot_img

Stay up-to-date with your field!

Subscribe for free weekly science newsletters.

Related News

Imatinib Blocks Tyrosine Phosphorylation of Smad4 and Restores TGF-β Growth-Suppressive Signaling in BCR-ABL1-Positive Leukemia

[Signal Transduction and Targeted Therapy] Investigators showed that the oncogenic BCR-ABL1 of chronic myelogenous leukemia and the cellular ABL1 tyrosine kinases phosphorylated and inactivated Smad4 to block antiproliferative TGF-β signaling.
Hematopoiesis NewsNewsletters
Read more

Toxicological Mechanism of Ammonia-N on Hematopoiesis and Apoptosis of Hemocytes in Litopenaeus vannamei

[Science of The Total Environment] RNA interference was performed to understand the function of astakine in hematopoiesis and apoptosis in Litopenaeus vannamei under ammonia-N exposure.
Hematopoiesis NewsNewsletters
Read more

Temporal Multimodal Single-Cell Profiling of Native Hematopoiesis Illuminates Altered Differentiation Trajectories with Age

[Cell Reports] The authors integrated extensive longitudinal functional assessments of HSC-specific lineage tracing with single-cell transcriptome and epitope profiling.
Hematopoiesis NewsNewsletters
Read more
Brought to you by